Educational information only. This site does not provide medical advice. Read full disclaimer
    PepTracker Pro
    Open the App
    Research-only content. This page is for educational purposes and does not constitute medical advice. Read full disclaimer →

    Kisspeptin-10

    Medium Evidence

    A neuropeptide that stimulates GnRH release, studied for fertility and reproductive hormone regulation.

    AliasesKP-10+1 more
    EvidenceMedium Evidence
    Last Updated 2026-05-27
    Reading Time 2 min

    What It Is

    Kisspeptin-10 is a truncated fragment of the kisspeptin family of peptides, which are products of the KISS1 gene and act as master regulators of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin signals through the GPR54 (KISS1R) receptor on GnRH neurons to trigger gonadotropin-releasing hormone (GnRH) secretion, which in turn stimulates LH and FSH release from the pituitary. This positions kisspeptin at the apex of reproductive endocrine signaling. Clinical research has demonstrated that kisspeptin-10 administration can safely stimulate LH pulses in healthy volunteers and in patients with hypothalamic amenorrhea, offering a physiological alternative to exogenous GnRH. In reproductive medicine, kisspeptin is being investigated as a trigger for oocyte maturation in IVF protocols, with early clinical data suggesting it may reduce the risk of ovarian hyperstimulation syndrome (OHSS) compared to hCG triggers. A 2025 Phase II trial at Imperial College London used kisspeptin-54 as an IVF trigger and reported comparable oocyte yield with significantly lower OHSS incidence. Beyond fertility, kisspeptin is studied for its effects on sexual behavior and psychosexual processing, with fMRI studies showing it enhances brain responses to sexual stimuli. Kisspeptin is not FDA-approved for any indication and remains investigational.

    Also known as: KP-10, Metastin fragment

    Why Researchers Study It

    Kisspeptin occupies a uniquely important position as the upstream regulator of the entire reproductive hormone cascade. Its potential to replace hCG triggers in IVF and reduce OHSS risk addresses a significant clinical need. The peptide also opens a novel pharmacological target for conditions involving HPG axis dysfunction, including hypogonadism, delayed puberty, and hypothalamic amenorrhea.

    Proposed Mechanisms

    • Binds GPR54 (KISS1R) on GnRH neurons, triggering GnRH pulsatile secretion
    • Stimulates downstream LH and FSH release from anterior pituitary gonadotrophs
    • Acts as a physiological trigger for oocyte maturation in IVF without sustained LH elevation
    • Modulates psychosexual processing via limbic circuit activation (demonstrated in fMRI studies)
    • May serve as an integrative signal linking metabolic status to reproductive function

    Evidence Snapshot

    Medium Evidence
    Low
    Medium
    High

    Commonly Discussed Benefits

    Safety & Cautions

    • Research ongoing in reproductive medicine
    • Effects on HPG axis require medical monitoring
    • Not approved for clinical use outside research settings
    • Short half-life may limit therapeutic applications

    Comparisons

    See how Kisspeptin-10 compares to related peptides:

    Calculator Tools

    Use our research tools to explore dosing and reconstitution data:

    Citations

    1. [1] Dhillo WS. et al. — Kisspeptin-54 stimulates gonadotropin release in humans. JCEM. 2005 PubMed

    Continue Your Research

    Track your research notes and set reminders in the companion app.

    Related Peptides

    HCG

    High Evidence

    A hormone used clinically for fertility treatment and testosterone support during hormone replacement therapy.

    HMG

    High Evidence

    A gonadotropin preparation containing FSH and LH, used in fertility protocols for both men and women.